Skip to main content

Table 3 The sensitivity of probiotic candidates against 30 antibiotics

From: Functional probiotics of lactic acid bacteria from Hu sheep milk

Types of Drugs Drug μg/pill HSM-1 HSM-10 HSM-14 HSM-18
Penicillins Penicillin 10 U 39 (S) 39(S) 37(S) 38(S)
Oxacillin 1 27 (S) 19(I) 20(I) 22(S)
Carboxycillin 100 42 (S) 44(S) 33(S) 40(S)
Piperacillin 100 48 (S) 29(S) 37(S) 42(S)
Ampicillin 100 31 (S) 35(S) 31(S) 32(S)
Cephalosporins Cephalexin 30 33 (S) 40(S) 29(S) 28(S)
Cefazolin 30 47 (S) 25(S) 27(S) 45(S)
Cefradine 30 34 (S) 44(S) 27(S) 32(S)
Ceftazidime 30 28 (S) 44(S) 17(I) 29(S)
Cefoperazone 75 41 (S) 40(S) 29(S) 37(S)
Cefatriaxone 30 41 (S) 38(S) 26(S) 35(S)
Cefuroxime 30 48 (S) 44(S) 36(S) 49(S)
Aminoglycosides Amikacin 30 19 (I) 19(I) 11(R) 24(S)
Kanamycin 30 25 (S) 21(S) 7(R) 20(I)
Neomycin 30 22 (S) 17(I) 15(R) 20(I)
Gentamicin 10 22 (S) 14(R) 12(R) 21(S)
Tetracycline Tetracycline 30 14 (R) 13(R) 29(S) 14(R)
Doxycycline 30 22 (S) 22(S) 28(S) 17(I)
Minocycline 30 30 (S) 27(S) 35(S) 26(S)
Macrolides Erythromycin 15 34 (S) 29(S) 28(S) 32(S)
Midecamycin 30 34 (S) 29(S) 23(S) 26(S)
Glycopeptides Vancomycin 30 31 (S) 25(S) 7(R) 26(S)
Quinolones Norfloxacin 10 18 (I) 16(I) 29(S) 25(S)
Ofloxacin 5 32 (S) 27(S) 29(S) 29(S)
Ciprofloxacin 5 27 (S) 26(S) 22(S) 21(S)
Furazolidone 300 23 (S) 17(I) 19(I) 29(S)
Chloramphenicol 30 39 (S) 36(S) 36(S) 36(S)
Clindamycin 2 41 (S) 37(S) 27(S) 40(S)
Sulfonamides Sulfamethoxazole (SMZ/TMP) 23.75/1.25 17 (I) 18(I) 8(R) 20(I)
Other classes Polymyxin 300 IU 22 (S) 5(R) 7(R) 24(S)
  1. Note: The zone of inhibition (diameter in mm) for each antibiotic was measured and expressed as susceptible, S (≥21 mm); intermediate, I (16–20 mm), and resistance, R(<=15 mm)